2013
DOI: 10.1161/hypertensionaha.113.00727
|View full text |Cite
|
Sign up to set email alerts
|

Are Observational Studies More Informative Than Randomized Controlled Trials in Hypertension?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
15
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 77 publications
1
15
0
Order By: Relevance
“…Recently, results from the Strong Heart Study, a population‐based cohort, including hypertensive patients with multiple cardiovascular risk factors and comorbidities, demonstrated an average increase in LV mass (LVM) during follow‐up, even in the subpopulation with optimal BP control . These findings suggest that in the real world, there might be problems in achieving effective LVH regression, which are not explored in clinical trials that are conducted in selected hypertensive populations …”
Section: Introductionmentioning
confidence: 99%
“…Recently, results from the Strong Heart Study, a population‐based cohort, including hypertensive patients with multiple cardiovascular risk factors and comorbidities, demonstrated an average increase in LV mass (LVM) during follow‐up, even in the subpopulation with optimal BP control . These findings suggest that in the real world, there might be problems in achieving effective LVH regression, which are not explored in clinical trials that are conducted in selected hypertensive populations …”
Section: Introductionmentioning
confidence: 99%
“…Specifically, the interaction of CV risk factors with structural and hemodynamic alterations as combined promoters of incident AF is not yet well studied [1], especially in a real-word context. The relatively disappointing results of strategies for primary prevention [5] might be at least in part due to the lack of a real-word approach, weighing all possible confounders [10].…”
Section: Introductionmentioning
confidence: 99%
“…However, because such results are usually obtained from a restricted dosing regimen in selected patients, it is difficult to generalize the demonstrated efficacy and safety (9,10). Therefore, such results have to be complemented by observational or surveillance studies before they are put to practical use in the routine clinical setting.…”
Section: Discussionmentioning
confidence: 99%